|
|
||||||||
Journal of Lipid Research, Vol 30, 1137-1145, Copyright © 1989 by Lipid Research, Inc.
B Staels, J Auwerx, L Chan, A van Tol, M Rosseneu and G Verhoeven
The influence of development and ethinylestradiol (EE) on apolipoprotein
(apo) A-I, A-II, and E mRNA in rat liver and intestine was studied by dot
blot hybridization and Northern blot analysis. ApoA- I mRNA levels were
maximal in the perinatal period and declined after day 15. An opposite
trend was noted for the apoA-II mRNA levels, whereas apoE mRNA remained
fairly constant. Liver apoA-I mRNA levels increased after ovariectomy
(OVX). A further rise was observed when EE was given at 2000
micrograms/day. When the influence of OVX and EE was controlled for food
intake by pair-feeding, OVX still increased hepatic apoA-I mRNA. The rise
in liver apoA-I mRNA after EE, however, was no longer significant. Under
the same conditions OVX slightly increased intestinal apoA-I mRNA. EE (2000
micrograms/day) decreased intestinal apoA-I mRNA to 80% of the pair-fed
controls. Liver apoA-II mRNA levels did not change after OVX when the
animals were fed ad libitum, but decreased slightly when the rats were
pair-fed. EE caused a dose- dependent decrease in liver apoA-II mRNA,
irrespective of food intake. None of these treatments caused any change in
liver apoE mRNA levels. Serum apoA-I levels increased upon OVX, while serum
apoE did not change. EE provoked a dose-dependent decrease of both
apolipoproteins in serum. In conclusion: 1) Changes in food intake play an
important role in the in vivo effects of estrogens on apolipoprotein mRNA
levels. 2) The stimulatory effect of OVX on hepatic apoA-I mRNA as well as
the inhibitory effect of EE on hepatic apoA-II mRNA are independent of food
intake.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Influence of development, estrogens, and food intake on apolipoprotein A-I, A-II, and E mRNA in rat liver and intestine
Laboratorium voor Experimentele Geneeskunde en Endocrinologie, Gasthuisberg, Katholieke Universiteit Leuven, Belgium.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
E. Grenier, F. S. Maupas, J.-F. Beaulieu, E. Seidman, E. Delvin, A. Sane, E. Tremblay, C. Garofalo, and E. Levy Effect of retinoic acid on cell proliferation and differentiation as well as on lipid synthesis, lipoprotein secretion, and apolipoprotein biogenesis Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1178 - G1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sauvaget, V. Chauffeton, S. Dugue-Pujol, A.-D. Kalopissis, I. Guillet-Deniau, F. Foufelle, J. Chambaz, A. Leturque, P. Cardot, and A. Ribeiro In Vitro Transcriptional Induction of the Human Apolipoprotein A-II Gene by Glucose Diabetes, March 1, 2004; 53(3): 672 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cui, N. W. Schoene, L. Zhu, J. C. Fanzo, A. Alshatwi, and K. Y. Lei Zinc depletion reduced Egr-1 and HNF-3beta expression and apolipoprotein A-I promoter activity in Hep G2 cells Am J Physiol Cell Physiol, August 1, 2002; 283(2): C623 - C630. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. P. Torra, V. Tsibulsky, F. Delaunay, R. Saladin, V. Laudet, J.-C. Fruchart, V. Kosykh, and B. Staels Circadian and Glucocorticoid Regulation of Rev-erb{alpha} Expression in Liver Endocrinology, October 1, 2000; 141(10): 3799 - 3806. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Couse and K. S. Korach Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us? Endocr. Rev., June 1, 1999; 20(3): 358 - 417. [Abstract] [Full Text] |
||||
![]() |
A. Mamontova, S. Seguret-Mace, B. Esposito, C. Chaniale, M. Bouly, N. Delhaye-Bouchaud, G. Luc, B. Staels, N. Duverger, J. Mariani, et al. Severe Atherosclerosis and Hypoalphalipoproteinemia in the Staggerer Mouse, a Mutant of the Nuclear Receptor ROR{alpha} Circulation, December 15, 1998; 98(24): 2738 - 2743. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Harnish, M. J. Evans, M. S. Scicchitano, R. A. Bhat, and S. K. Karathanasis Estrogen Regulation of the Apolipoprotein AI Gene Promoter through Transcription Cofactor Sharing J. Biol. Chem., April 10, 1998; 273(15): 9270 - 9278. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. K. Srivastava, N. Srivastava, M. Averna, R. C. Lin, K. S. Korach, D. B. Lubahn, and G. Schonfeld Estrogen Up-regulates Apolipoprotein E (ApoE) Gene Expression by Increasing ApoE mRNA in the Translating Pool via the Estrogen Receptor alpha -Mediated Pathway J. Biol. Chem., December 26, 1997; 272(52): 33360 - 33366. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Vu-Dac, P. Gervois, T. Grotzinger, P. De Vos, K. Schoonjans, J.-C. Fruchart, J. Auwerx, J. Mariani, A. Tedgui, and B. Staels Transcriptional Regulation of Apolipoprotein A-I Gene Expression by the Nuclear Receptor RORalpha J. Biol. Chem., September 5, 1997; 272(36): 22401 - 22404. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Lundeen, J. M. Carver, M.-L. McKean, and R. C. Winneker Characterization of the Ovariectomized Rat Model for the Evaluation of Estrogen Effects on Plasma Cholesterol Levels Endocrinology, April 1, 1997; 138(4): 1552 - 1558. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Kauffman, W. R. Bensch, R. E. Roudebush, H. W. Cole, J. S. Bean, D. L. Phillips, A. Monroe, G. J. Cullinan, A. L. Glasebrook, and H. U. Bryant Hypocholesterolemic Activity of Raloxifene (LY139481): Pharmacological Characterization as a Selective Estrogen Receptor Modulator J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 146 - 153. [Abstract] [Full Text] |
||||
![]() |
S. Seguret-Mace, M. Latta-Mahieu, G. Castro, G. Luc, J.-C. Fruchart, E. Rubin, P. Denefle, and N. Duverger Potential Gene Therapy for Lecithin-Cholesterol Acyltransferase (LCAT)–Deficient and Hypoalphalipoproteinemic Patients With Adenovirus-Mediated Transfer of Human LCAT Gene Circulation, November 1, 1996; 94(9): 2177 - 2184. [Abstract] [Full Text] |
||||
![]() |
B Staels and J Auwerx Perturbation of developmental gene expression in rat liver by fibric acid derivatives: lipoprotein lipase and alpha-fetoprotein as models Development, January 8, 1992; 115(4): 1035 - 1043. [Abstract] [PDF] |
||||
![]() |
J. Ladias and S. Karathanasis Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily Science, February 1, 1991; 251(4993): 561 - 565. [Abstract] [PDF] |
||||
![]() |
J. Dallongeville, E. Bauge, A. Tailleux, J. M. Peters, F. J. Gonzalez, J.-C. Fruchart, and B. Staels Peroxisome Proliferator-activated Receptor alpha Is Not Rate-limiting for the Lipoprotein-lowering Action of Fish Oil J. Biol. Chem., February 9, 2001; 276(7): 4634 - 4639. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |